In this study, we report the presence of TF+ CD4+ T cells in the inflamed mucosa of paediatric IBD patients and colitogenic mice, uncover the thrombogenic phenotype of activated CD4+ T cells, and demonstrate a new role for activated PC signalling in mitigating CD4+ T cell thrombo-inflammatory activity. This evidence concerns the gene CD4 and inflammatory bowel disease.